Black Diamond Therapeutics, Inc.

Black Diamond Therapeutics, Inc.verified

BDTX

Price:

$5.99

Market Cap:

$336.95M

Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 driver mutations. The company is also developing BDTX-1535, a brain-penetrant inhibitor of EGFR mutations, including canonical, intrinsic resistance, and acquired resistance mutations; and BDTX-4933, a brain-penetrant inhibitor of oncogenic BRAF class I, II and III alterations. It has a strategic partnership with OpenEye ...[Read more]

Industry

Biotechnology

IPO Date

2020-01-31

Stock Exchange

NASDAQ

Ticker

BDTX

The PE Ratio as of July 2024 (TTM) for Black Diamond Therapeutics, Inc. (BDTX) is -3.61

According to Black Diamond Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -3.61. This represents a change of 54.13% compared to the average of -2.34 of the last 4 quarters.

Black Diamond Therapeutics, Inc. (BDTX) Historical PE Ratio (quarterly & annually)

How has BDTX PE Ratio performed in the past?

The mean historical PE Ratio of Black Diamond Therapeutics, Inc. over the last ten years is -25.40. The current -3.61 PE Ratio has changed 1.32% with respect to the historical average. Over the past ten years (40 quarters), BDTX's PE Ratio was at its highest in in the September 2022 quarter at -0.74. The PE Ratio was at its lowest in in the December 2018 quarter at -44.91.

Quarterly (TTM)
Annual

Average

-25.40

Median

-16.11

Minimum

-61.73

Maximum

-0.77

Black Diamond Therapeutics, Inc. (BDTX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Black Diamond Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 93.66%

Maximum Annual PE Ratio = -0.77

Minimum Annual Increase = -90.28%

Minimum Annual PE Ratio = -61.73

Quarterly (TTM)
Annual
YearPE RatioChange
2023-1.5093.66%
2022-0.77-50.59%
2021-1.57-90.28%
2020-16.11-53.26%
2019-34.46-44.12%
2018-61.67-0.10%

Black Diamond Therapeutics, Inc. (BDTX) Average PE Ratio

How has BDTX PE Ratio performed in the past?

The current PE Ratio of Black Diamond Therapeutics, Inc. (BDTX) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-1.28

5-year avg

-10.88

10-year avg

-25.40

Black Diamond Therapeutics, Inc. (BDTX) PE Ratio vs. Peers

How is BDTX’s PE Ratio compared to its peers?

Black Diamond Therapeutics, Inc.’s PE Ratio is less than Passage Bio, Inc. (0), less than TCR2 Therapeutics Inc. (-0.60), less than Harpoon Therapeutics, Inc. (-0.44), less than Alector, Inc. (-2.94), greater than Revolution Medicines, Inc. (-4.64), greater than Atreca, Inc. (-16.01), less than Stoke Therapeutics, Inc. (-0.04), greater than Homology Medicines, Inc. (-5.94), less than Adaptimmune Therapeutics plc (-0.01), less than null (-1.84),

Build a custom stock screener for Black Diamond Therapeutics, Inc. (BDTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Black Diamond Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Black Diamond Therapeutics, Inc. (BDTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Black Diamond Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Black Diamond Therapeutics, Inc.'s PE Ratio?

How is the PE Ratio calculated for Black Diamond Therapeutics, Inc. (BDTX)?

What is the highest PE Ratio for Black Diamond Therapeutics, Inc. (BDTX)?

What is the 3-year average PE Ratio for Black Diamond Therapeutics, Inc. (BDTX)?

What is the 5-year average PE Ratio for Black Diamond Therapeutics, Inc. (BDTX)?

How does the current PE Ratio for Black Diamond Therapeutics, Inc. (BDTX) compare to its historical average?